VanEck Associates
TECH icon

VanEck Associates’s Bio-Techne TECH Stock Holding History

VanEck Associates’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.7M Sell
293,165
-24,033
-8% -$1.3M 0.01% 438
2026
Q1 		$16.6M Buy
317,198
+53,311
+20% +$3.2M 0.01% 473
2025
Q4 		$15.5M Buy
263,887
+30,646
+13% +$1.86M 0.01% 448
2025
Q3 		$13M Sell
233,241
-52,779
-18% -$2.83M 0.01% 462
2025
Q2 		$14.7M Buy
286,020
+60,430
+27% +$3.04M 0.02% 388
2025
Q1 		$13.2M Buy
225,590
+54,033
+31% +$3.66M 0.02% 400
2024
Q4 		$12.4M Buy
171,557
+49,574
+41% +$3.64M 0.02% 410
2024
Q3 		$8.46M Sell
121,983
-20,226
-14% -$1.52M 0.01% 497
2024
Q2 		$10.2M Buy
142,209
+3,373
+2% +$248K 0.01% 411
2024
Q1 		$9.77M Sell
138,836
-4,065
-3% -$291K 0.01% 408
2023
Q4 		$11M Sell
142,901
-22,664
-14% -$1.49M 0.02% 347
2023
Q3 		$11.3M Buy
165,565
+7,096
+4% +$561K 0.02% 322
2023
Q2 		$12.9M Sell
158,469
-5,787
-4% -$465K 0.03% 307
2023
Q1 		$12.2M Sell
164,256
-24,551
-13% -$1.89M 0.03% 315
2022
Q4 		$15.6M Buy
188,807
+39,531
+26% +$3.14M 0.04% 269
2022
Q3 		$10.6M Sell
149,276
-62,852
-30% -$5.43M 0.03% 299
2022
Q2 		$18.4M Buy
212,128
+11,564
+6% +$1.08M 0.05% 251
2022
Q1 		$21.7M Buy
200,564
+9,832
+5% +$1.01M 0.04% 240
2021
Q4 		$24.7M Sell
190,732
-4,864
-2% -$596K 0.06% 228
2021
Q3 		$23.7M Buy
+195,596
New +$23.8M 0.06% 233
2021
Q2 		– Sell
-840
Closed -$80K – 1312
2021
Q1 		$80K Buy
+840
New +$76.6K ﹤0.01% 1032

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

VanEck Associates's TECH Position: Q2 2026 in Review

VanEck Associates reduced its Bio-Techne (TECH) stake by 7.6% in Q2 2026, selling an estimated $1.3M and leaving 293,165 shares worth $20.7M. The position accounts for 0.01% of the portfolio, ranked #438.

VanEck Associates first reported a position in TECH in Q1 2021 and has held it in 21 quarters since. The position peaked at $24.7M in Q4 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • VanEck Associates held 293,165 shares of Bio-Techne worth $20.7M as of Q2 2026.
  • VanEck Associates sold 24,033 Bio-Techne shares in Q2 2026, an estimated $1.3M.
  • Bio-Techne made up 0.01% of VanEck Associates's portfolio in Q2 2026, its #438 holding.
  • VanEck Associates first reported a position in Bio-Techne in Q1 2021 and has held it in 21 quarters since.
  • VanEck Associates's Bio-Techne position peaked at $24.7M in Q4 2021.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.